ENT A toluidine blue mouthrinse for detecting oral cancer, specifically SCC which accounts for 95% of oral CA. See Oral cancer, Toluidin blue.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
The decrease in R&D is due to the curtailment of the OraTest regulatory program.
has strengthened its biotechnology business, reported on OraTest funding, added key personnel and expanded on several other objectives.
Proceeds will be a principal source of funding for tolonium chloride and OraTest programs.
The OraTest oral cancer detection system from Zila, Inc.
These patents are connected with Zila's oral cancer detection product, OraTest. The new patent covers the use of the oxadine and thiazine classes of dyes in detecting cancer by direct application to the oral tissues.
The Pharmaceuticals/Biomedical Group includes: Zila Pharmaceuticals, marketer of prescription and non-prescription oral healthcare products; Zila Biomedical, introducing the OraTest oral cancer detection product worldwide; and Zila Manufacturing, producer of the only pharmaceutical-grade toluidine blue - Zila Tolonium Chloride.
Those costs have accelerated sharply over the last year, as we are launching new products at Nutraceuticals and Pharmaceuticals and advancing our OraTest regulatory effort.
They will take a new mouth rinse check called OraTest which will dye invisible lesions blue.
(Nasdaq:ZILA), has reported strong revenue growth for the first quarter of its 2003 fiscal year, while restructuring costs and strategic investments in marketing, product development, the OraTest clinical trial and the launch of ViziLite led to a larger net loss, compared with the prior-year period.
-- develop, test and launch new products, including OraTest (an increase of $276,000 in Phase III clinical trial costs vs.
During the third quarter of fiscal 2002, the company invested $1,018,000 in the OraTest(R)/Zila(R) Tolonium Chloride program, which encompasses the OraTest oral cancer detection product Phase III clinical trial, other OraTest research, and the broad Zila Tolonium Chloride research, development and manufacturing effort.